Lindane

Lindane

SCHEMBL3672215

Cl.Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl.NCCN(CCN)CCN1CCN(CCN)CC1

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

823298382338688239847Rdl1Rdl2Rdl3

The experimentally established mechanism targets of Lindane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.48
SIGMAR1 Q99720 2/20 0.41
ACE2 Q9BYF1 1/20 0.31
ALDH1A1 P00352 1/20 0.30
PRMT3 O60678 1/20 0.30
CARM1 Q86X55 1/20 0.30
PRMT6 Q96LA8 1/20 0.30
PRMT1 Q99873 1/20 0.30
PRMT8 Q9NR22 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3672217 0.90 ALOX15 (0.59) ALOX15SIGMAR1ACE2ALDH1A1PRMT3
SCHEMBL29041543 0.88 ALOX15 (0.62) ALOX15SIGMAR1ACE2ALDH1A1PRMT3
SCHEMBL14980599 0.79 ALOX15 (0.50) ALOX15SIGMAR1ACE2ALDH1A1
SCHEMBL19072067 0.77 ALOX15 (0.52) ALOX15SIGMAR1ACE2ALDH1A1
SCHEMBL9064037 0.76 ALOX15 (0.44) ALOX15SIGMAR1ALDH1A1
SCHEMBL14980601 0.75 ALOX15 (0.42) ALOX15SIGMAR1ACE2ALDH1A1
SCHEMBL8406067 0.74 SIGMAR1 (0.54) ALOX15SIGMAR1ALDH1A1
SCHEMBL17705625 0.74 ALOX15 (0.43) ALOX15SIGMAR1ACE2
SCHEMBL21214195 0.73 GNAI3 (0.43) ALOX15SIGMAR1PRMT3CARM1PRMT6
SCHEMBL19071651 0.71 ALOX15 (0.42) ALOX15SIGMAR1ACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2139461-A2 AMINO DERIVATIVES TO PREVENT NEPHROTOXICITY AND CANCER Recepticon Aps (DK) 2010-01-06 EP disclosed
WO-2008113364-A2 AMINO DERIVATIVES TO PREVENT NEPHROTOXICITY AND CANCER RECEPTICON APS (DK) 2008-09-25 WO disclosed